EndoCure Pioneers Robotic Ultrasound Technology

Led by a repeat founder and a world-renowned robotics pioneer, the Israeli startup EndoCure has developed a robotic platform capable of producing 3D images with 10 times the density of an MRI.

“Current imaging methods, MRI, CT, and manual ultrasound, often fail to detect small or deep tumors, are highly operator-dependent, and are either expensive, invasive, or inconsistent,” says EndoCure. “This creates major gaps in diagnosis, delays in treatment, unnecessary surgeries, and poor patient outcomes.”

Founded in 2023 by Dr. Hadas Ziso, a repeat founder with 20 years of MedTech experience, and Prof. Moshe Shoham, a robotics pioneer who was behind the $1.6B Mazor Robotics exit, EndoCure has raised $2.7 million to date and is seeking to address the aforementioned gap with Revealan, a proprietary robotic ultrasound platform. The startup is currently moving through clinical studies, including a trial for bladder cancer monitoring at Bnai Zion Medical Center.

Ultimately, Revealan is gearing to shift “ultrasound from a subjective tool to a reliable, scalable platform, opening new possibilities for diagnostics, personalized treatment, and improved outcomes.”

Learn more about EndoCure and the founding team at calcalistech.com.

Prof. Moshe Shoham, co-founder of EndoCure, is a renowned global expert in medical robotics, and a professor emeritus in the faculty of mechanical engineering at the Technion.